Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 황승균 | - |
dc.date.accessioned | 2018-05-18T08:15:15Z | - |
dc.date.available | 2018-05-18T08:15:15Z | - |
dc.date.issued | 2005 | - |
dc.identifier.issn | 1042-3680 | - |
dc.identifier.other | OAK-2602 | - |
dc.identifier.uri | https://dspace.ewha.ac.kr/handle/2015.oak/243197 | - |
dc.description.abstract | Untreated cerebral AVMs carry a significant risk of long-term morbidity and mortality. Endovascular embolization has evolved into an important treatment option for most AVMs, whether it is used as an adjunct or as the primary therapy. Although sometimes a challenge to use, liquid cyanoacrylate derivatives have become the material of choice for most practitioners performing endovascular AVM embolization. In addition, advances in flow-guided microcatheter technology have enabled safer access to ever more hard-to-reach areas of the cerebral vasculature. In the current era, the treatment of cerebral AVMs seems to be best approached from a multidisciplinary standpoint at facilities where the major treatment modalities of microsurgery, stereotactic radiosurgery, and endovascular embolization are all available. | - |
dc.language | English | - |
dc.title | Endovascular treatment of cerebral arteriovenous malformations: Indications, techniques, outcome, and complications | - |
dc.type | Review | - |
dc.relation.issue | 2 SPEC. ISS. | - |
dc.relation.volume | 16 | - |
dc.relation.index | SCIE | - |
dc.relation.index | SCOPUS | - |
dc.relation.startpage | 367 | - |
dc.relation.lastpage | 380 | - |
dc.relation.journaltitle | Neurosurgery Clinics of North America | - |
dc.identifier.doi | 10.1016/j.nec.2004.08.001 | - |
dc.identifier.wosid | WOS:000227342700016 | - |
dc.identifier.scopusid | 2-s2.0-13244255466 | - |
dc.author.google | Cockroft K.M. | - |
dc.author.google | Hwang S.-K. | - |
dc.author.google | Rosenwasser R.H. | - |
dc.contributor.scopusid | 황승균(35187436400) | - |
dc.date.modifydate | 20180517114100 | - |